Form 4 for PMN ProMIS Neurosciences Inc.

Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0000899243-23-018462 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-08-25	2023-08-23	PMN	Cashman Neil	CSO, Dir	A - Grant	—	+10.6K	113.3K	+10%	—
D	2023-08-25	2023-08-23	PMN	Cashman Neil	CSO, Dir	A - Grant	—	+10.6K	10.6K	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2023-08-23	A	A	10,643	—	113,304	D	—	—	(F1) On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 10,643 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.
2	Derivative	Warrants to purchase Common Shares	2023-08-23	A	A	10,643	—	10,643	D	$1.75 · 2024-02-21 to 2029-02-21	10,643 Common Shares	(F1) On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 10,643 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.